Singapore, Jan 18, 2010: Australian city Brisbane has been selected to host the 2011 International Conference on Mechanisms of Action of Nutraceuticals (ICMAN5), said Queensland Premier Anna Bligh in New York over the weekend.

It’s expected that more than 400 delegates will convene at the Brisbane Convention and Exhibition Center on October 13-15, 2011, to take part in this premier complementary medicines conference, what has become a key event in the international nutraceutical and complementary medicines industry calendar.

Brisbane ICMAN Bid Convenor and the CEO of host organization Queensland Clinical Trials Network (QCTN), Mario Pennisi, said the city secured the bid due to its excellent research facilities and active industry stakeholders, contributing to Queensland’s growing prominence in the pharmaceutical and nutraceutical industry.

“Brisbane has been selected as the host city for ICMAN5, thanks to its world-class research infrastructure, convention facilities, proximity to emerging Asian markets in the pharmaceutical

industry as well as the state’s own nation-leading industry,” said Mr Pennisi.